awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33404428-31AC7C29-0DC9-47BF-A156-853D6AFC9E29
Q33404428-31AC7C29-0DC9-47BF-A156-853D6AFC9E29
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33404428-31AC7C29-0DC9-47BF-A156-853D6AFC9E29
Phase II study of cisplatin and oral VP16 in patients with refractory or relapsed Ewing sarcoma.
P2860
Q33404428-31AC7C29-0DC9-47BF-A156-853D6AFC9E29
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33404428-31AC7C29-0DC9-47BF-A156-853D6AFC9E29
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c6a0aa23575c75a756e9ccae51803bce8f24b9c4
P2860
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.